A Case of Spontaneously Resolving Cushing Disease. [PDF]
O'Brolchain A, Ryder S, Berkman K.
europepmc +1 more source
The effect of cabergoline on folicular microenviroment profile in patients with high risk of OHSS [PDF]
Emine Güven+4 more
openalex +1 more source
Cabergoline-induced cerebrospinal fluid fistulae in macroprolactinomas. [PDF]
Hermann EJ+8 more
europepmc +1 more source
High-dose Hook Effect in a Case of Giant Prolactinoma Confounded by Acute Kidney Injury. [PDF]
Lam A, Prosser C, Chik CL.
europepmc +1 more source
Can dopamine agonist cabergoline reduce ovarian hyperstimulation syndrome in art treatment cycles? A prospective randomized study [PDF]
Hadar Amir+3 more
openalex +1 more source
Response to cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort study. [PDF]
Rudman Y+9 more
europepmc +1 more source
Elevated Dehydroepiandrosterone Sulfate Levels in 2 Patients With Prolactinomas: An Underrecognized Association. [PDF]
Arguinchona J+4 more
europepmc +1 more source
Dopamine D<sub>2</sub> receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progression. [PDF]
Alam SK+10 more
europepmc +1 more source